Page last updated: 2024-11-05

8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate and Alloxan Diabetes

8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate has been researched along with Alloxan Diabetes in 1 studies

8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate: intracellular calcium antagonist; RN given refers to parent cpd

Research Excerpts

ExcerptRelevanceReference
" From cumulative dose-response curves, pD2 values of various calcium antagonists for the negative inotropic activity were determined in diabetic and control hearts."1.28Effects of various calcium antagonists in isolated perfused hearts from diabetic and age-matched control rats. ( Heijnis, JB; Mathy, MJ; van Zwieten, PA, 1991)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Heijnis, JB1
Mathy, MJ1
van Zwieten, PA1

Other Studies

1 other study available for 8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate and Alloxan Diabetes

ArticleYear
Effects of various calcium antagonists in isolated perfused hearts from diabetic and age-matched control rats.
    Journal of cardiovascular pharmacology, 1991, Volume: 17, Issue:6

    Topics: Animals; Calcium; Calcium Channel Blockers; Depression, Chemical; Diabetes Mellitus, Experimental; D

1991